ReElement Technologies stock soars after securing $1.4B government deal
Craig E. Hunsaker, Executive Vice President, People & Culture at Alphatec Holdings, Inc. (NASDAQ:ATEC), sold 100,000 shares of common stock on October 31, 2025, for a total of $1.99 million.
The shares were sold at a weighted average price of $19.95, with individual sales prices ranging from $19.90 to $20.00. Following the transaction, Hunsaker directly owns 1,289,142 shares of Alphatec Holdings . The company’s stock is trading near its 52-week high, with analysts setting a high price target of $23, according to InvestingPro data.
The sale was executed under a pre-arranged Rule 10b5-1 trading plan adopted on March 5, 2025. Despite not being profitable in the last twelve months, Alphatec has demonstrated strong revenue growth of 26.27% and appears overvalued based on InvestingPro’s Fair Value assessment. For deeper insights and additional ProTips on ATEC, explore the comprehensive Pro Research Report available for this and 1,400+ US equities.
In other recent news, Alphatec Holdings reported its third-quarter 2025 earnings, showcasing significant improvements in both revenue and earnings per share (EPS). The company exceeded expectations by reporting an EPS of $0.03, compared to an anticipated loss of $0.04, resulting in a 175% surprise. Revenue for the quarter reached $197 million, reflecting a 30% year-over-year growth. Piper Sandler responded to these strong results by raising its price target for Alphatec to $25.00, maintaining an Overweight rating. Similarly, Canaccord Genuity increased its price target to $25.00 from $20.00, sustaining a Buy rating. Canaccord highlighted that Alphatec’s surgical revenue grew by 31%, with EOS imaging technology revenue increasing by 29%. The company also reported nearly 30% growth in surgical volume and 26% growth in new surgeon users during the quarter. These developments indicate continued market share gains for Alphatec in the spine surgery sector.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.